Overview

Detailed Summary

Kronox Lab Sciences Limited manufactures High Purity Speciality Fine Chemicals for diverse industries. Established in 2009, it has expanded into key sectors such as pharmaceuticals, nutraceuticals, and solar industries.
The company plays a crucial role in pharmaceuticals by providing essential reagents and excipients, impacting the production of APIs.
Kronox's chemicals are also integral to scientific research, laboratory testing, and various formulations across agrochemicals and personal care products.
The upcoming IPO aims to raise Rs 45 crore, signaling strategic capital deployment for further expansion and operational effectiveness.

Sector: Chemicals & Petrochemicals
Industry: Specialty Chemicals
Market Cap: 490 Cr
Volatility: High Risk
P/E Ratio: 17.8
Industry P/E: 42.6
PEG Ratio: 0.8
P/B Ratio: 4.3
52W High: 207.40
52W Low: 96.00

Sales CAGR

1Y: 11.50%
3Y: 6.80%
5Y: 14.69%
10Y: —

Profit CAGR

1Y: 19.30%
3Y: 23.18%
5Y: 24.27%
10Y: —

ROE

TTM: 23.82%
3Y: 31.43%
5Y: 32.27%
10Y: —

ROCE

TTM: 31.78%
3Y: 42.15%
5Y: 42.77%
10Y: —

Technicals

‌

Forecasts

Peers

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VIPULORG		269.90	514 Cr	74.43	4.39	0.30	5.90	6.94	2.98
CHEMBONDCH		184.85	497 Cr	14.21	2.40	0.68	16.89	22.08	13.72
KRONOX		131.75	497 Cr	18.04	4.28	0.37	23.82	31.78	21.60
BLACKROSE		93.11	477 Cr	21.26	2.81	0.00	13.23	18.43	10.79
SKM		389.00	477 Cr	26.30	7.36	0.00	22.50	17.99	9.72
PLASTIBLEN		173.15	449 Cr	12.23	1.00	1.74	8.17	10.56	6.58
NIKHILAD		89.00	405 Cr	23.34	2.78	0.00	11.92	13.89	5.19
Median: 7 Co.	—	173.15	477 Cr	21.26	2.81	0.30	13.23	17.99	9.72

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	21	22	25	25	24	26	24	26	25	26
Expenses	14	14	17	16	16	18	16	17	17	17
Operating Profit	6.31	7.86	8.20	8.80	8.37	7.75	7.97	8.64	8.02	9.52
OPM %	30.47	35.44	32.55	35.40	34.86	29.66	32.81	33.84	31.74	36.43
Other Income	0.42	0.83	0.43	0.36	0.82	0.91	0.87	1.04	1.13	2.15
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.04	0.04
Depreciation	0.30	0.29	0.33	0.34	0.36	0.35	0.40	0.47	0.52	0.66
Profit Before Tax	6.42	8.40	8.31	8.82	8.83	8.31	8.44	9.18	8.60	11
Tax %	24.61	29.88	25.99	26.64	26.05	24.07	25.59	27.23	23.37	27.07
Net Profit	4.84	5.88	6.15	6.47	6.53	6.32	6.28	6.68	6.59	8.00
EPS in Rs	—	—	1.67	1.76	1.77	1.72	1.70	1.82	1.79	2.18

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	51	62	82	96	90	100	99
Expenses	39	48	63	74	62	67	66
Operating Profit	12	15	20	22	28	33	33
OPM %	23.19	23.70	23.95	22.72	31.51	33.06	33.13
Other Income	1.07	0.78	1.09	1.92	1.58	2.53	2.96
Interest	0.08	0.38	0.41	0.09	0.00	0.00	0.00
Depreciation	0.96	1.98	2.03	1.50	1.29	1.38	1.45
Profit Before Tax	12	13	18	22	29	34	34
Tax %	26.77	26.40	25.76	25.58	25.37	25.69	25.58
Net Profit	8.59	9.73	14	16	21	25	26
EPS in Rs	—	—	—	—	5.83	6.92	7.49
Dividend Payout %	0.00	0.00	0.00	0.00	8.61	7.24	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.25	0.24	0.24	37	37	37
Reserves	23	27	40	7.65	29	53
Borrowings	0.01	3.62	3.36	0.00	0.00	0.00
Other Liabilities	11	7.21	13	9.28	7.69	8.72
Total Liabilities	34	38	57	54	74	99
Fixed Assets	5.54	9.19	11	16	26	28
CWIP	0.00	0.40	0.00	0.00	0.49	0.76
Investments	0.03	0.03	0.03	0.03	0.03	0.03
Other Assets	29	28	45	38	47	70
Total Assets	34	38	57	54	74	99

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	4.48	11	9.02	20	17	31
Cash from Investing Activity	-3.92	-2.96	-7.60	-6.60	-17	-28
Cash from Financing Activity	-0.21	-7.10	-0.67	-13	0.00	-1.85
Net Cash Flow	0.35	1.26	0.76	-0.33	0.10	0.45

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Nov 2023	Jan 2024	May 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	100.00%	100.00%	100.00%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%
FIIs	0.00%	0.00%	0.00%	1.56%	0.55%	0.48%	0.04%	0.03%	0.03%	0.05%	0.08%
DIIs	0.00%	0.00%	0.00%	5.43%	2.57%	2.20%	2.20%	1.71%	1.93%	2.00%	2.05%
Public	0.00%	0.00%	0.00%	18.80%	22.67%	23.11%	23.55%	24.05%	23.83%	23.75%	23.66%
Total Shareholders	9	9	9	32,604	39,792	38,489	37,922	37,569	35,780	34,608	33,469

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Kronox Lab Sciences Ltd

Kronox Lab Sciences Ltd (KRONOX) is currently trading at 132.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Kronox Lab Sciences Limited manufactures High Purity Speciality Fine Chemicals for diverse industries. Established in 2009, it has expanded into key sectors such as pharmaceuticals, nutraceuticals, and solar industries. The company plays a crucial role in pharmaceuticals by providing essential reagents and excipients, impacting the production of APIs. Kronox's chemicals are also integral to scientific research, laboratory testing, and various formulations across agrochemicals and personal care products. The upcoming IPO aims to raise Rs 45 crore, signaling strategic capital deployment for further expansion and operational effectiveness.

Over the past 52 weeks, Kronox Lab Sciences Ltd has traded between a low of ₹96.00 and a high of ₹207.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Kronox Lab Sciences Ltd has a market capitalization of approximately 497.01. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Kronox Lab Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 18.04 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 497.01 Cr, Kronox Lab Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Kronox Lab Sciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Kronox Lab Sciences Ltd is 18.04. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The IPO opened on 3 June 2024 and closed on 5 June 2024.

Kronox Lab Sciences Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock more with professional

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Kronox Lab Sciences Ltd

What is Kronox Lab Sciences Ltd share price today?

What does Kronox Lab Sciences Ltd do?

What is the 52-week high and low of Kronox Lab Sciences Ltd?

What is the market capitalization of Kronox Lab Sciences Ltd?

Should I consider investing in Kronox Lab Sciences Ltd stock?

Is Kronox Lab Sciences Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Kronox Lab Sciences Ltd belong to and why does it matter?

What is the PE ratio of Kronox Lab Sciences Ltd?

When did Kronox Lab Sciences IPO open and close?

Investor’s Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Kronox Lab Sciences Ltd

What is Kronox Lab Sciences Ltd share price today?

What does Kronox Lab Sciences Ltd do?

What is the 52-week high and low of Kronox Lab Sciences Ltd?

What is the market capitalization of Kronox Lab Sciences Ltd?

Should I consider investing in Kronox Lab Sciences Ltd stock?

Is Kronox Lab Sciences Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Kronox Lab Sciences Ltd belong to and why does it matter?

What is the PE ratio of Kronox Lab Sciences Ltd?

When did Kronox Lab Sciences IPO open and close?

Announcements

Oscillators

Bearish

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist